UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Leading hepatitis C drug wins FDA nod for adolescents
by Kim Yun-mi
2019-05-03 15:51
New head of HUMC to put focus on research
by Kim Yun-mi
2019-05-02 16:57
‘MSD Korea’s monitoring program might be privacy breach’
by Kim Yun-mi
2019-05-02 11:00
Drugmakers brace for vaccine shortage amid surging hepatitis A cases
by Kim Yun-mi
2019-04-30 13:13
Breast cancer society to focus on patients’ quality of life
by Kim Yun-mi
2019-04-26 14:22
라인
‘PD-L1 expression poor marker for bladder cancer’s immunotherapy’
by Kim Yun-mi
2019-04-25 11:52
[News Focus] Cholesterol-reducing PCSK9 inhibitors get popular -- cost-effective, too?
by Kim Yun-mi
2019-04-24 12:35
How to improve treatment guidelines for dyslipidemia?
by Kim Yun-mi
2019-04-22 14:50
‘No need to reduce number of drugs for triple-drug therapy to treat HIV’
by Kim Yun-mi
2019-04-18 15:20
Novartis’ new macular degeneration drug has to compete against colon cancer drug Avastin. Why?
by Kim Yun-mi
2019-04-18 14:42
라인
Immunotherapies’ liver cancer-treating effects confirmed in real-world studies
by Kim Yun-mi
2019-04-15 14:29
Doctors skeptical about GSK’s new HIV drug despite FDA nod
by Kim Yun-mi
2019-04-11 13:55
Saxenda no silver bullet for weight loss, doctors warn
by Kim Yun-mi
2019-04-05 16:21
[Reporter’s Notebook] Concerns over TB risk rise amid more use of TNF-α inhibitors
by Kim Yun-mi
2019-03-29 17:21
Korean women more prone to infection with HPV-52, 58
by Kim Yun-mi
2019-03-28 15:03
라인
[Special] Interleukin inhibitors Cosentyx, Taltz target psoriasis market
by Kim Yun-mi
2019-03-26 14:56
Setback in search for Alzheimer’s drug: Biogen halts phase-3 aducanumab trials
by Kim Yun-mi
2019-03-22 15:50
Korea closing in on tailored gene therapies to fight cancer
by Kim Yun-mi
2019-03-21 11:47
[Special] PCSK9 inhibitors aim to replace statin in cholesterol reduction
by Kim Yun-mi
2019-03-18 15:49
Reimbursement for orphan drug Spinraza imminent
by Kim Yun-mi
2019-03-18 12:02
-
이전
11
12
13
14
15
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top